Reply to: Safety of dopamine agonists for treating restless legs syndrome

Mov Disord. 2019 Jan;34(1):150-151. doi: 10.1002/mds.27571.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dopamine Agonists
  • Humans
  • Restless Legs Syndrome*

Substances

  • Dopamine Agonists